Related Experiment Video
Updated: May 5, 2026

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
Published on: March 8, 2019
Retracted: Curcumin Improves Pulmonary Hypertension Rats by Regulating Mitochondrial Function
This article has been retracted. The retraction notice indicates that the original publication is no longer considered valid by the authors or journal editors.
Area of Science:
- Scientific publishing standards
- Retraction policies
- Academic integrity
Context:
- The article identified by DOI 10.1155/2021/1078019 has been retracted.
- Retractions are formal announcements that a scientific publication is no longer considered valid.
- This action is typically due to serious flaws in methodology, data, or ethical concerns.
Purpose:
- To formally announce the retraction of a specific scientific article.
- To inform the scientific community about the invalidity of the publication.
- To maintain the integrity of the scientific record.
Summary:
- The article with DOI 10.1155/2021/1078019 is officially retracted.
- This retraction signifies that the findings or conclusions presented in the original article are no longer considered reliable.
- The reasons for retraction are detailed in the official notice.
Impact:
- Ensures the accuracy and reliability of scientific literature.
- Prevents the dissemination of potentially flawed or misleading research.
- Upholds ethical standards in scientific communication.
More Related Videos
07:41A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
07:11Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
Published on: May 23, 2025
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...